Cargando…

Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol

Early acute kidney rejection remains an important clinical issue. METHODS. The current study included 552 recipients who had 1–2 surveillance or indication biopsy within the 1 y posttransplant. We evaluated the impact of type of allograft inflammation on allograft outcome. They were divided into 5 g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owoyemi, Itunu, Tandukar, Srijan, Jorgensen, Dana R., Wu, Christine M., Sood, Puneet, Puttarajappa, Chethan, Sharma, Akhil, Shah, Nirav A., Randhawa, Parmjeet, Molinari, Michele, Tevar, Amit D., Mehta, Rajil B., Hariharan, Sundaram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191698/ https://www.ncbi.nlm.nih.gov/pubmed/34124342 http://dx.doi.org/10.1097/TXD.0000000000001132

Ejemplares similares

Kidney Transplant Outcomes After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: A Single-Center Experience
por: Sood, Puneet, et al.
Publicado: (2016)

Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing
por: Kalluri, Hari V., et al.
Publicado: (2020)

High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
por: Sharma, Akhil, et al.
Publicado: (2019)

Liver Enzymes and the Development of Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
por: Klaassen, Gerald, et al.
Publicado: (2017)

Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation
por: Sharma, Akhil, et al.
Publicado: (2019)

Development and Validation of a New Score to Assess the Risk of Posttransplantation Diabetes Mellitus in Kidney Transplant Recipients
por: Serna-Higuita, Lina Maria, et al.
Publicado: (2023)

HLA Alleles Cw12 and DQ4 in Kidney Transplant Recipients Are Independent Risk Factors for the Development of Posttransplantation Diabetes
por: Phagura, Nuvreen, et al.
Publicado: (2021)

Autosomal Dominant Polycystic Kidney Disease Is a Risk Factor for Posttransplantation Diabetes Mellitus: An Updated Systematic Review and Meta-analysis
por: Culliford, Alice, et al.
Publicado: (2020)

Reexamining the Impact of Insurance Type on Kidney Transplant Waitlist Status and Posttransplantation Outcomes in the United States After Implementation of the Affordable Care Act
por: Morenz, Anna, et al.
Publicado: (2023)

Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical Reevaluation
por: Pan, Ling, et al.
Publicado: (2018)

Impact of Size Matching Based on Donor-Recipient Height on Kidney Transplant Outcomes
por: Tandukar, Srijan, et al.
Publicado: (2022)

Does Kidney Transplantation Affect Sleep and Fatigue in Patients With Kidney Disease?
por: Tandukar, Srijan, et al.
Publicado: (2019)

Medication, Healthcare Follow-up, and Lifestyle Nonadherence: Do They Share the Same Risk Factors?
por: Ng, Yue-Harn, et al.
Publicado: (2021)

The Clinical Impact of Anti-HLA Donor Specific Antibody Detection Through First Year Screening on Stable Kidney Transplant Recipients
por: Sharma, Akhil, et al.
Publicado: (2022)

The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant
por: Nimmo, Ailish M. S. A., et al.
Publicado: (2018)

The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation
por: Brifkani, Zaid, et al.
Publicado: (2017)

Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021)

Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
por: van Sandwijk, Marit S., et al.
Publicado: (2018)

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal
por: Pierce, Dana R., et al.
Publicado: (2021)

Kidney Rejection Following Simultaneous Liver-kidney Transplantation
por: Shah, Sapna, et al.
Publicado: (2020)

Function and longevity of renal grafts from high‐KDPI donors
por: Molinari, Michele, et al.
Publicado: (2022)

Hyperacute Antibody-mediated Rejection Associated With Red Blood Cell Antibodies
por: Shaw, James, et al.
Publicado: (2019)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Outcomes and factors leading to graft failure in kidney transplants from deceased donors with acute kidney injury—A retrospective cohort study
por: Jung, Cheol Woong, et al.
Publicado: (2021)

Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
por: Parajuli, Sandesh, et al.
Publicado: (2017)

Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis
por: Wehmeier, Caroline, et al.
Publicado: (2017)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury
por: Bijkerk, Roel, et al.
Publicado: (2017)

The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts
por: Abu Jawdeh, Bassam G., et al.
Publicado: (2022)

Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Efficacy and Safety of Tocilizumab in the Treatment of Acute Active Antibody-mediated Rejection in Kidney Transplant Recipients
por: Pottebaum, April A., et al.
Publicado: (2020)

A Combined microRNA and Chemokine Profile in Urine to Identify Rejection After Kidney Transplantation
por: Gielis, Els M., et al.
Publicado: (2021)

Acute Kidney Allograft Rejection Following Coronavirus mRNA Vaccination: A Case Report
por: Bau, Jason T., et al.
Publicado: (2022)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome
por: van den Hoogen, Martijn W.F., et al.
Publicado: (2017)

Response to Treatment for Chronic-active T Cell–mediated Rejection in Kidney Transplantation: A Report of 3 Cases
por: Noguchi, Hiroshi, et al.
Publicado: (2020)

Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss
por: Petr, Vojtech, et al.
Publicado: (2021)

How Should Acute T-cell Mediated Rejection of Kidney Transplants Be Treated: Importance of Follow-up Biopsy
por: Aziz, Fahad, et al.
Publicado: (2022)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_61pfou9s6s953l5o3la38a5a03